Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials

Overview of attention for article published in BMJ Open Respiratory Research, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

patent: 1 patent

Readers on

mendeley: 35 Mendeley

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 7,253 followers.

RT @SamirNus: Dose modification of pirfenidone in IPF b/o adverse effects still slows FVC deterioration significantly in a dose depndent ma…

RT @gburgeILDNN: Dose modification of pirfenidone because of adverse events has little effect on FVC @ild_inn @ipf_manchester @smagers12…

RT @SamirNus: Dose modification of pirfenidone in IPF b/o adverse effects still slows FVC deterioration significantly in a dose depndent ma…

RT @gburgeILDNN: Dose modification of pirfenidone because of adverse events has little effect on FVC @ild_inn @ipf_manchester @smagers12…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.